Nick Taylor to step down as CEO, Neil Humphrey named successor
LONDON, Sept. 17, 2024 /PRNewswire/ — After 42 years at Waterman, including 17 years as Chief Executive, Nick Taylor has decided to step down from the Waterman Group Plc Board on 31st March 2025.
Nick will be succeeded on 1st April 2025 by Neil Humphrey, who is currently the Chief Operating Officer of UK and has been an integral part of the Waterman team since 2001.
From 1st April 2025, Nick will continue to support Waterman as Non-Executive Chairman and will retain his position as a Director of Waterman’s businesses in Ireland and Australia. This transition has been carefully planned over several years, with the next generation of leaders increasingly taking on more active and responsible roles within Waterman’s organisational structure.
About Waterman Group
Waterman Group is a multidisciplinary consultancy providing sustainable solutions to meet the planning, engineering design and project delivery needs of the property, infrastructure, environment and energy markets. The company specialises in civil, structural, transportation, mechanical and electrical engineering as well as sustainability and construction related health and safety consultancy. Founded in 1952, Waterman has since grown into a leading engineering and environmental consultancy with offices throughout the UK, Australia and Europe. See more information on www.watermangroup.com. Waterman Group is part of CTI Engineering, a leading Japanese engineering consultancy specialising in civil engineering and construction works, including planning, research, design, and project management www.ctie.co.jp/english/.
Photo – https://mma.prnasia.com/media2/2507384/Waterman_Group.jpg?p=medium600
Photo – https://mma.prnasia.com/media2/2507385/Waterman_MDs.jpg?p=medium600

Đề xuất
Nebu Ease Portable Nebulizer Claims Evaluated: 2026 Consumer Research Report on Mesh Nebulizer Technology, Respiratory Comfort Features, and What Buyers Should Verify
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations
Sherry Cummings, CEO of Gryphon Healthcare, Named One of the Top 50 Women to KNOW in Texas
Direct Meds GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference